For the Inventor, By the Inventor

Enter assignee name

Henderson, Auckland, New Zealand

Douglas Pharmaceuticals Limited

USPTO Granted Patents = 16

CIPO Patents = 1

EPO Patents = 2

Trademarks = 5

Forward Citations = 56

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

Paul William Glue (10 out of 11 patents)

Natalie June Medlicott (10 out of 11 patents)

Peter William Surman (10 out of 11 patents)

4. Ian Hampson (3 out of 5 patents)

5. Lynne Hampson (3 out of 5 patents)

6. Andrew David Abell (2 out of 2 patents)

7. James Morriss Coxon (2 out of 2 patents)

8. Matthew Alan Jones (2 out of 2 patents)

9. Stephen Brian McNabb (2 out of 2 patents)

10. Axel Thomas Neffe (2 out of 2 patents)

11. Steven Geoffrey Aitken (2 out of 2 patents)

12. Blair Gibb Stuart (2 out of 2 patents)

13. Janna Marie Nikkel (2 out of 2 patents)

14. Joanna Kimberley Duncan (2 out of 2 patents)

15. Mutita Klanchantra (2 out of 2 patents)

16 patents: Sort by Forward Citations

1. 12472146 - Extended release pharmaceutical formulation (2025-11-18),

2. 12414994 - Compositions comprising lopinavir and treatment of conditions (2025-09-16),

3. 12350378 - Extended release pharmaceutical formulation and methods of treatment (2025-07-08),

4. 12128140 - Extended release pharmaceutical formulation (2024-10-29),

5. 12090123 - Extended release pharmaceutical formulation (2024-09-17),

6. 12083120 - Treatments (2024-09-10),

7. 11738024 - Lopinavir and ritonavir for the treatment of cervix disorders (2023-08-29),

8. 11471416 - Extended release pharmaceutical formulation and methods of treatment (2022-10-18),

9. 11471415 - Extended release pharmaceutical formulation and methods of treatment (2022-10-18),

10. 11045424 - Extended release pharmaceutical formulation (2021-06-29),

11. 10869838 - Extended release pharmaceutical formulation (2020-12-22),

12. 10744094 - Extended release pharmaceutical formulation (2020-08-18),

13. 10441544 - Extended release pharmaceutical formulation (2019-10-15),

14. 9434762 - Macrocyclic cysteine protease inhibitors and compositions thereof (2016-09-06),

15. 8710178 - Macrocyclic cysteine protease inhibitors and compositions thereof (2014-04-29),

Douglas Pharmaceuticals Limited is a privately-owned New Zealand pharmaceutical company dedicated to developing and manufacturing high-quality products. With over 50 years of experience, the company offers a wide range of pharmaceuticals, skincare, and healthcare products that are distributed globally. Douglas Pharmaceuticals is committed to innovation, research, and quality, ensuring that their products meet the highest standards.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

16 Patents

#1 in Henderson, Auckland

#42 in New Zealand

#36,651 in the World

Henderson, Auckland, New Zealand

Douglas Pharmaceuticals Limited

Forward Citations = 56

25 inventors:

Paul William Glue (10 out of 11 patents)

Natalie June Medlicott (10 out of 11 patents)

Peter William Surman (10 out of 11 patents)

4. Ian Hampson (3 out of 5 patents)

5. Lynne Hampson (3 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…